Owning discovered the palmitoylation motif of APLNR, we developed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the event of NCP, together with pain incidence, microglial activation, and inflammatory factor launch https://proleviate.com/block-pain-receptors-with-conolidine/